- 2017 Balance by Quarter Change Q1–18 Q4–17 Q1–17 Q1–18 VS Q4–17 Q1–18 VS Q1–17 (Million Baht: MB) (MB) % (MB) % Total Revenue 1,044.9 1,279.4 1,139.2 (234.5) (18.3) (94.3) (8.3) Total Operating Expenses
financial statements for the three-month period ended 31 March 2019 and 2020 Revenues Q1/20 Q1/19 Change +/(-) Revenue from hotel operations 232 367 (36.9) Revenue from property development operations 238 115
Statement 2Q 2Q % 6 mth 6 mth % Unit : THB million 2018 2017 change 2018 2017 change Revenue from non-social security 212.10 178.03 19% 430.34 355.30 21% Revenue from social security 171.37 153.92 11% 336.06
follows: Statements of Comprehensive Income for the 2nd Quarter Ended June 30, 2019 Revenue from Hospital Operations Revenue from hospital operations in the second quarter of 2019 (“2Q’19”) was THB 422.77
change Revenue from non-social security 220.70 196.97 12% 911.16 772.76 18% Revenue from social security 173.29 170.13 2% 676.28 630.31 7% Revenue from Hospital Operations 393.99 367.10 7% 1,587.43
www.interpharma.co.th Inter Pharma Co. Ltd. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th Type of Revenue 2019 2018 Change MB
Summary of operations and the factors that make a significant change Summary of Operations for the Year 2017 Topic Annual Balance Change 2017 2016 2017 VS 2016 (MB) (MB) % Total Revenue 5,397.2 4,419.1
Q3–2020 Balance by Quarter Change Q3–20 Q2–20 Q3–19 Q3–20 VS Q2–20 Q3–20 VS Q3–19 (Million Baht: MB) (MB) % (MB) % Total Revenue 2,241.1 1,187.6 1,798.9 1,053.5 88.7 442.2 24.6 Total Operating Expenses
70.6 MB. -2- The change in net profit in 2023 is consistent with the change in revenue when compared to 2022. However, in 2023, the profits decreased by 7. 0% , while total revenue decreased by 3. 1